Inhibition of T cell activation by cyclic adenosine 5′-monophosphate requires lipid raft targeting of protein kinase A type I by the A-kinase anchoring protein Ezrin

Journal of Immunology

Volumn 179, Issue 8, 2007, Pages 5159-5168

  Ruppelt, Anja ^a   Mosenden, Randi ^a   Grönholm, Mikaela ^b   Aandahl, Einar M ^a   Tobin, Derek ^a,e   Carlson, Cathrine R ^a,f   Abrahamsen, Hilde ^a,g   Herberg, Friedrich W ^c   Carpén, Olli ^a,d   Taskén, Kjetil ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF KASSEL   (Germany)

^d TURKU UNIVERSITY HOSPITAL   (Finland)

^e DiaGenic ASA   (Norway)

^f ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE PHOSPHATE; APC PROTEIN; BINDING PROTEIN; CYCLIC AMP DEPENDENT PROTEIN KINASE 1; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; EZRIN; EZRIN BINDING PROTEIN 50; GLYCOSPHINGOLIPID; INTERLEUKIN 2; MULTIPROTEIN COMPLEX; PHOSPHOPROTEIN; PROTEIN TYROSINE KINASE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; ACTIN; CYCLIC AMP; CYTOSKELETON PROTEIN; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIGEN RECEPTOR; SODIUM HYDROGEN EXCHANGER REGULATORY FACTOR; SODIUM PROTON EXCHANGE PROTEIN; SODIUM-HYDROGEN EXCHANGER REGULATORY FACTOR;

ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; FAR WESTERN BLOTTING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; LIPID RAFT; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN TARGETING; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TWO HYBRID SYSTEM; YEAST; CELL CULTURE; CELL MEMBRANE; CHEMISTRY; CYTOSKELETON; DRUG ANTAGONISM; ENZYMOLOGY; GENETICS; IMMUNOLOGY; LEUKEMIA CELL LINE; METABOLISM; MOLECULAR CLONING; PEPTIDE MAPPING; PHYSIOLOGY; SIGNAL TRANSDUCTION;

A KINASE ANCHOR PROTEINS; ACTINS; CELLS, CULTURED; CLONING, MOLECULAR; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASE TYPE I; CYTOSKELETAL PROTEINS; CYTOSKELETON; HUMANS; IMMUNOSUPPRESSIVE AGENTS; JURKAT CELLS; MEMBRANE MICRODOMAINS; PEPTIDE MAPPING; PHOSPHOPROTEINS; PROTEIN BINDING; RECEPTOR-CD3 COMPLEX, ANTIGEN, T-CELL; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SODIUM-HYDROGEN ANTIPORTER; T-LYMPHOCYTES;

EID: 38449120815     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.8.5159     Document Type: Article

References (63)

1. Tasken, K., and E. M. Aandahl. 2004. Localized effects of cAMP mediated by distinct routes of protein kinase A. Physiol. Rev. 84: 137-167.
2. Michel, J. J. C., and J. D. Scott. 2002. AKAP mediated signal transduction. Annu. Rev. Pharmacol. Toxicol. 42: 235-257.
3. Wong, W., and J. D. Scott. 2004. AKAP signalling complexes: focal points in space and time. Nat. Rev. Mol. Cell Biol. 5: 959-970.
4. Skalhegg, B. S., K. Tasken, V. Hansson, H. S. Huitfeldt, T. Jahnsen, and T. Lea. 1994. Location of cAMP-dependent protein kinase type I with the TCR-CD3 complex. Science 263: 84-87.
5. Vang, T., K. M. Torgersen, V. Sundvold, M. Saxena, F. O. Levy, B. S. Skalhegg, V. Hansson, T. Mustelin, and K. Tasken. 2001. Activation of the COOH-terminal Src kinase (Csk) by cAMP-dependent protein kinase inhibits signaling through the T cell receptor. J. Exp. Med. 193: 497-507.
6. Tsukita, S., K. Oishi, N. Sato, J. Sagara, A. Kawai, and S. Tsukita. 1994. Erm family members as molecular linkers between the cell-surface glycoprotein Cd44 and actin-based cytoskeletons. J. Cell Biol. 126: 391-401.
7. Yonemura, S., M. Hirao, Y. Doi, N. Takahashi, T. Kondo, S. Tsukita, and S. Tsukita. 1998. Ezrin/Radixin/Moesin (ERM) proteins bind to a positively charged amino acid cluster in the juxta-membrane cytoplasmic domain of CD44, CD43, and ICAM-2. J. Cell Biol. 140: 885-895.
8. + translocation. Mol. Cell 6: 1425-1436.
9. Bono, P., K. Rubin, J. M. G. Higgins, and R. O. Hynes. 2001. Layilin, a novel integral membrane protein, is a hyaluronan receptor. Mol. Biol. Cell 12: 891-900.
10. Heiska, L., K. Alfthan, M. Gronholm, P. Vilja, A. Vaheri, and O. Carpen. 1998. Association of ezrin with intercellular adhesion molecule-1 and -2 (ICAM-1 and ICAM-2): regulation by phosphatidylinositol 4, 5-bisphosphate. J. Biol. Chem. 273: 21893-21900.
11. Takahashi, K., T. Sasaki, A. Mammoto, K. Takaishi, T. Kameyama, S. Tsukita, S. Tsukita, and Y. Takai. 1997. Direct interaction of the Rho GDP dissociation inhibitor with ezrin/radixin/moesin initiates the activation of the Rho small G protein. J. Biol. Chem. 272: 23371-23375.
12. Takahashi, K., T. Sasaki, A. Mammoto, I. Hotta, K. Takaishi, H. Imamura, K. Nakano, A. Kodama, and Y. Takai. 1998. Interaction of radixin with Rho small G protein GDP/GTP exchange protein Dbl. Oncogene 16: 3279-3284.
13. Bretscher, A., K. Edwards, and R. G. Fehon. 2002. ERM proteins and merlin: integrators at the cell cortex. Nat. Rev. Mol. Cell Biol. 3: 586-599.
14. Dransfield, D. T., A. J. Bradford, J. Smith, M. Martin, C. Roy, P. H. Mangeat, and J. R. Goldenring. 1997. Ezrin is a cyclic AMP-dependent protein kinase anchoring protein. EMBO J. 16: 35-43.
15. Sun, F., M. J. Hug, N. A. Bradbury, and R. A. Frizzell. 2000. Protein kinase A associates with cystic fibrosis transmembrane conductance regulator via an interaction with ezrin. J. Biol. Chem. 275: 14360-14366.
16. Brdicka, T., D. Pavlistova, A. Leo, E. Bruyns, V. Korinek, P. Angelisova, J. Scherer, A. Shevchenko, I. Hilgert, J. Cerny, et al. 2000. Phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), a novel ubiquitously expressed transmembrane adaptor protein, binds the protein tyrosine kinase csk and is involved in regulation of T cell activation. J. Exp. Med. 191: 1591-1604.
17. Kawabuchi, M., Y. Satomi, T. Takao, Y. Shimonishi, S. Nada, K. Nagai, A. Tarakhovsky, and M. Okada. 2000. Transmembrane phosphoprotein Cbp regulates the activities of Src-family tyrosine kinases. Nature 404: 999-1003.
18. Gronholm, M., M. Sainio, F. Zhao, L. Heiska, A. Vaheri, and O. Carpen. 1999. Homotypic and heterotypic interaction of the neurofibromatosis 2 tumor suppressor protein merlin and the ERM protein ezrin. J. Cell Sci. 112: 895-904.
19. Holen, T., M. Amarzguioui, M. T. Wiiger, E. Babaie, and H. Prydz. 2002. Positional effects of short interfering RNAs targeting the human coagulation trigger tissue factor. Nucleic Acids Res. 30: 1757-1766.
20. Aandahl, E. M., P. Aukrust, B. S. Skalhegg, F. Muller, S. S. Froland, V. Hansson, and K. Tasken. 1998. Protein kinase A type I antagonist restores immune responses of T cells from HIV-infected patients. FASEB J. 12: 855-862.
21. Helander, T. S., O. Carpen, O. Turunen, P. E. Kovanen, A. Vaheri, and T. Timonen. 1996. ICAM-2 redistributed by ezrin as a target for killer cells. Nature 382: 265-268.
22. Tasken, K., K. B. Andersson, B. S. Skalhegg, K. A. Tasken, V. Hansson, T. Jahnsen, and H. K. Blomhoff. 1993. Reciprocal regulation of mRNA and protein for subunits of cAMP-dependent protein kinase (RIα and Cα) by cAMP in a neoplastic B cell line (Reh). J. Biol. Chem. 268: 23483-23489.
23. Carr, D. W., R. E. Stofkohahn, I. D. C. Fraser, S. M. Bishop, T. S. Acott, R. G. Brennan, and J. D. Scott. 1991. Interaction of the regulatory subunit (Rii) of cAMP-dependent protein-kinase with Rii-anchoring proteins occurs through an amphipathic helix binding motif. J. Biol. Chem. 266: 14188-14192.
24. Witczak, O., B. S. Skalhegg, G. Keryer, M. Bornens, K. Tasken, T. Jahnsen, and S. Orstavik. 1999. Cloning and characterization of a cDNA encoding an A-kinase anchoring protein located in the centrosome, AKAP450. EMBO J. 18: 1858-1868.
25. Huang, L. J. S., K. Durick, J. A. Weiner, J. Chun, and S. S. Taylor. 1997. Identification of a novel protein kinase A anchoring protein that binds both type I and type II regulatory subunits. J. Biol. Chem. 272: 8057-8064.
26. Huang, L. J. S., K. Durick, J. A. Weiner, J. Chun, and S. S. Taylor. 1997. D-AKAP2, a novel protein kinase A anchoring protein with a putative RGS domain. Proc. Natl. Acad. Sci. USA 94: 11184-11189.
27. Carlson, C. R., A. Ruppelt, and K. Tasken. 2003. A kinase anchoring protein (AKAP) interaction and dimerization of the RI and RI regulatory subunits of protein kinase A in vivo by the yeast two hybrid system. J. Mol. Biol. 327: 609-618.
28. Li, H., B. Degenhardt, D. Tobin, Z. X. Yao, K. Tasken, and V. Papadopoulos. 2001. Identification, localization, steroidogenesis of PAP7: a peripheral-type benzodiazepine receptor- and PKA (RIα)-associated protein. Mol. Endocrinol. 15: 2211-2228.
29. Schillace, R. V., S. F. Andrews, G. A. Liberty, M. P. Davey, and D. W. Carr. 2002. Identification and characterization of myeloid translocation gene 16b as a novel A kinase anchoring protein in T lymphocytes. J. Immunol. 168: 1590-1599.
30. Gary, R., and A. Bretscher. 1995. Ezrin self-association involves binding of an N-terminal domain to a normally masked C-terminal domain that includes the F-actin binding-site. Mol. Biol. Cell 6: 1061-1075.
31. 2+ channel activity by cAMP-dependent protein kinase. Proc. Natl. Acad. Sci. USA 94: 11067-11072.
32. Herberg, F. W., A. Maleszka, T. Eide, L. Vossebein, and K. Tasken. 2000. Analysis of A-kinase anchoring protein (AKAP) interaction with protein kinase A (PKA) regulatory subunits: PKA isoform specificity in AKAP binding. J. Mol. Biol. 298: 329-339.
33. Stokka, A. J., F. Gesellchen, C. R. Carlson, J. D. Scott, F. W. Herberg, and K. Tasken. 2006. Characterization of A-kinase anchoring disruptors using a solution based assay. Biochem. J. 400: 493-499.
34. Allenspach, E. J., P. Cullinan, J. K. Tong, Q. Z. Tang, A. G. Tesciuba, J. L. Cannon, S. M. Takahashi, R. Morgan, J. K. Burkhardt, and A. I. Sperling. 2001. ERM-dependent movement of CD43 defines a novel protein complex distal to the immunological synapse. Immunity 15: 739-750.
35. Vang, T., H. Abrahamsen, S. Myklebust, V. Horejsi, and K. Tasken. 2003. Combined spatial and enzymatic regulation of Csk by cAMP and protein kinase A inhibits T cell receptor signaling. J. Biol. Chem. 278: 17597-17600.
36. Brdickova, N., T. Brdicka, L. Andera, J. Spicka, P. Angelisova, S. L. Milgram, and V. Horejsi. 2001. Interaction between two adapter proteins, PAG and EBP50: a possible link between membrane rafts and actin cytoskeleton. FEBS Lett. 507: 133-136.
37. Lester, L. B., L. K. Langeberg, and J. D. Scott. 1997. Anchoring of protein kinase A facilitates hormone-mediated insulin secretion. Proc. Natl. Acad. Sci. USA 94: 14942-14947.
38. Miki, K., and E. M. Eddy. 1998. Identification of tethering domains for protein kinase A type Iα regulatory subunits on sperm fibrous sheath protein FSC1. J. Biol. Chem. 273: 34384-34390.
39. Reinton, N., P. Collas, T. B. Haugen, B. S. Skalhegg, V. Hansson, T. Jahnsen, and K. Tasken. 2000. Localization of a novel human A-kinase-anchoring protein, hAKAP220, during spermatogenesis. Dev. Biol. 223: 194-204.
40. Lin, R. Y., S. B. Moss, and C. S. Rubin. 1995. Characterization of S-AKAP84, a novel developmentally regulated A kinase anchor protein of male germ cells. J. Biol. Chem. 270: 27804.
41. Trendelenburg, G., M. Hummel, E. O. Riecken, and C. Hanski. 1996. Molecular characterization of AKAP149, a novel A kinase anchor protein with a KH domain. Biochem. Biophys. Res. Commun. 225: 313-319.
42. χ subunit of protein kinase A. J. Biol. Chem. 278: 41167-41172.
43. Carlson, C. R., B. Lygren, T. Berge, N. Hoshi, W. Wong, K. Tasken, and J. D. Scott. 2006. Delineation of type I protein kinase A-selective signaling events using an RI anchoring disruptor. J. Biol. Chem. 281: 21535-21545.
44. Gautreau, A., D. Louvard, and M. Arpin. 2000. Morphogenic effects of ezrin require a phosphorylation-induced transition from oligomers to monomers at the plasma membrane. J. Cell Biol. 150: 193-203.
45. Matsui, T., M. Maeda, Y. Doi, S. Yonemura, M. Amano, K. Kaibuchi, S. Tsukita, and S. Tsukita. 1998. Rho-kinase phosphorylates COOH-terminal threonines of ezrin/radixin/moesin (ERM) proteins and regulates their head-to-tail association. J. Cell Biol. 140: 647-657.
46. Nakamura, F., M. R. Amieva, and H. Furthmayr. 1995. Phosphorylation of threonine 558 in the carboxyl-terminal actin-binding domain of moesin by thrombin activation of human platelets. J. Biol. Chem. 270: 31377-31385.
47. Nguyen, R., D. Reczek, and A. Bretscher. 2001. Hierarchy of merlin and ezrin N- and C-terminal domain interactions in homo- and heterotypic associations and their relationship to binding of scaffolding proteins EBP50 and E3KARP. J. Biol. Chem. 276: 7621-7629.
48. Granes, F., J. M. Urena, N. Rocamora, and S. Vilaro. 2000. Ezrin links syndecan-2 to the cytoskeleton. J. Cell Sci. 113: 1267-1276.
49. Altman, A., and M. Villalba. 2003. Protein kinase C-θ (PKCθ): it's all about location, location, location. Immunol. Rev. 192: 53-63.
50. Altman, A., N. Isakov, and G. Baier. 2000. Protein kinase Cθ: a new essential superstar on the T-cell stage. Immunol. Today 21: 567-573.
51. Mustelin, T., and K. Tasken. 2003. Positive and negative regulation of T-cell activation through kinases and phosphatases. Biochem. J. 371: 15-27.
52. Brown, M. J., R. Nijhara, J. A. Hallam, M. Gignac, K. M. Yamada, S. L. Erlandsen, J. Delon, M. Kruhlak, and S. Shaw. 2003. Chemokine stimulation of human peripheral blood T lymphocytes induces rapid dephosphorylation of ERM proteins, which facilitates loss of microvilli and polarization. Blood 102: 3890-3899.
53. Faure, S., L. I. Salazar-Fontana, M. Semichon, V. L. Tybulewicz, G. Bismuth, A. Trautmann, R. N. Germain, and J. Delon. 2004. ERM proteins regulate cytoskeleton relaxation promoting T cell-APC conjugation. Nat. Immunol. 5: 272-279.
54. Kimberley, F. C., B. Sivasankar, and M. B. Paul. 2007. Alternative roles for CD59. Mol. Immunol. 44: 73-81.
55. Dobenecker, M. W., C. Schmedt, M. Okada, and A. Tarakhovsky. 2005. The ubiquitously expressed Csk adaptor protein Cbp is dispensable for embryogenesis and T-cell development and function. Mol. Cell. Biol. 25: 10533-10542.
56. Xu, S., J. Huo, J. E. Tan, and K. P. Lam. 2005. Cbp deficiency alters Csk localization in lipid rafts but does not affect T-cell development. Mol. Cell. Biol. 25: 8486-8495.
57. Manjunath, N., M. Correa, M. Ardman, and B. Ardman. 1995. Negative regulation of T-cell adhesion and activation by Cd43. Nature 377: 535-538.
58. Walker, J., and J. M. Green. 1999. Structural requirements for CD43 function. J. Immunol. 162: 4109-4114.
59. Thurman, E. C., J. Walker, S. Jayaraman, N. Manjunath, B. Ardman, and J. M. Green. 1998. Regulation of in vitro and in vivo T cell activation by CD43. Int. Immunol. 10: 691-701.
60. Sperling, A. I., J. R. Sedy, N. Manjunath, A. Kupfer, B. Ardman, and J. K. Burkhardt. 1998. Cutting edge: TCR signaling induces selective exclusion of CD43 from the T cell-antigen-presenting cell contact site. J. Immunol. 161: 6459-6462.
61. Tong, J. K., E. J. Allenspach, S. M. Takahashi, P. D. Mody, C. Park, J. K. Burkhardt, and A. I. Sperling. 2004. CD43 regulation of T cell activation is not through steric inhibition of T cell-APC interactions but through an intracellular mechanism. J. Exp. Med. 199: 1277-1283.
62. Aandahl, E. M., W. J. Moretto, P. A. Haslett, T. Vang, T. Bryn, K. Tasken, and D. F. Nixon. 2002. Inhibition of antigen-specific T cell proliferation and cytokine production by protein kinase A type I. J. Immunol. 169: 802-808.
63. 2-dependent mechanism. J. Immunol. 177: 246-254.